All Peptides
Thymosin Alpha-1

Thymosin Alpha-1

Immune system optimizer

$275/mo

Virtual consult required

This peptide requires a brief virtual visit before our team can prescribe.

Details

Virtual Consult

Our licensed provider reviews your health profile via secure video — typically 10 minutes. Required for any peptide prescription.

Refund Policy: If found not eligible due to health reasons after consultation, you will receive a full refund.

Product Details

About Thymosin Alpha-1

Mechanism of Action

Thymosin Alpha-1 is a 28-amino acid peptide that enhances T-cell maturation and differentiation, increases MHC expression on antigen-presenting cells, and modulates cytokine production for balanced immune response. It enhances NK cell activity and dendritic cell function. Importantly, it acts as an immunomodulator—normalizing function whether overactive or underactive.

Scientific Background

Discovered in the 1960s, Ta1 helps restore thymic function that declines with age. Approved in over 30 countries for chronic hepatitis B and C. Research shows efficacy in chemotherapy-induced immunosuppression, HIV/AIDS, and severe infections. Also demonstrates anti-aging effects by maintaining immune surveillance against senescent and pre-cancerous cells.

Clinical Applications

Used for immune optimization in healthy individuals and adjunctive therapy for serious diseases. Valuable during cold/flu season, high-stress periods, or travel. Being investigated as cancer therapy adjunct to enhance checkpoint inhibitors. Can improve vaccine responses in elderly/immunocompromised patients.

Evidence-Based

Clinical Research & Studies

Backed by peer-reviewed research from leading medical journals

2013
Peer Reviewed

Thymosin alpha-1 as an immunomodulatory therapy for chronic viral infections

Systematic review demonstrating Thymosin Alpha-1 improves immune function and viral clearance in chronic hepatitis B and C, with enhanced T-cell responses and normalized cytokine profiles.

Read Full Study
2020
Peer Reviewed

Thymosin α1 in the treatment of cancer: from bench to bedside

Review of Ta1 in cancer therapy showing it enhances immune responses against tumors, improves outcomes when combined with conventional treatments, and reduces treatment-related immunosuppression.

Read Full Study
2017
Peer Reviewed

Immunomodulatory effects of Thymosin Alpha-1 in immunosenescence

Research demonstrating Ta1 can partially reverse age-related immune dysfunction by enhancing T-cell function, improving vaccine responses, and restoring immune surveillance in elderly individuals.

Read Full Study
Explore More

Related Resources

Similar Peptide Therapies

NAD+
$350/mo

NAD+

Cellular energy and longevity

Learn More
SS-31
$250/mo

SS-31

Mitochondrial protection peptide

Learn More
GHK-Cu
$275/mo

GHK-Cu

Copper peptide for skin rejuvenation

Learn More

Educational Articles

Article

Thymosin Alpha-1: Optimizing Immune Function for Longevity

Read Article
Article

Peptide Therapy for Immune Support and Disease Prevention

Read Article